| Year |
Citation |
Score |
| 2023 |
Ruco A, Cernat A, Calleja S, Tinmouth J, Lofters AK. Primary care provider interventions for addressing cancer screening participation with marginalised patients: a scoping review protocol. Bmj Open. 13: e066005. PMID 37076157 DOI: 10.1136/bmjopen-2022-066005 |
0.581 |
|
| 2021 |
Walker MJ, Meggetto O, Gao J, Espino-Hernández G, Jembere N, Bravo CA, Rey M, Aslam U, Sheppard AJ, Lofters AK, Tammemägi MC, Tinmouth J, Kupets R, Chiarelli AM, Rabeneck L. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study. Preventive Medicine. 151: 106586. PMID 34217413 DOI: 10.1016/j.ypmed.2021.106586 |
0.58 |
|
| 2020 |
Paszat LF, Sutradhar R, Corn E, Luo J, Baxter NN, Tinmouth J, Rabeneck L. Morbidity and mortality following major large bowel resection for colorectal cancer detected by a population-based screening program. Journal of Medical Screening. 969141320957361. PMID 32954965 DOI: 10.1177/0969141320957361 |
0.366 |
|
| 2020 |
Cenin DR, Tinmouth J, Naber SK, Dubé C, McCurdy BR, Paszat L, Rabeneck L, Lansdorp-Vogelaar I. Calculation of Stop ages for Colorectal Cancer Screening Based on Comorbidities and Screening History. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 32450362 DOI: 10.1016/J.Cgh.2020.05.038 |
0.366 |
|
| 2020 |
Ruco A, Dossa F, Tinmouth J, Llovet D, Kishibe T, Baxter NN. Social media and mobile health technology for cancer screening: a systematic review and meta-analysis protocol. Bmj Open. 10: e035411. PMID 32029500 DOI: 10.1136/Bmjopen-2019-035411 |
0.383 |
|
| 2019 |
Litwin O, Sontrop JM, McArthur E, Tinmouth J, Rabeneck L, Vinden C, Sood MM, Baxter NN, Tanuseputro P, Welk B, Garg AX. Uptake of Colorectal Cancer Screening by Physicians is Associated With Greater Uptake by Their Patients. Gastroenterology. PMID 31682852 DOI: 10.1053/J.Gastro.2019.10.027 |
0.397 |
|
| 2019 |
Dube C, Tinmouth J. Number of samples in faecal immunochemical test screening: more might be less. The Lancet. Gastroenterology & Hepatology. 4: 577-578. PMID 31196733 DOI: 10.1016/S2468-1253(19)30191-8 |
0.306 |
|
| 2018 |
Leddin D, Lieberman DA, Tse F, Barkun AN, Abou-Setta AM, Marshall JK, Samadder NJ, Singh H, Telford JJ, Tinmouth J, Wilkinson AN, Leontiadis GI. Clinical Practice Guideline on Screening for Colorectal Cancer in individuals with a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus. Gastroenterology. PMID 30121253 DOI: 10.1053/J.Gastro.2018.08.017 |
0.381 |
|
| 2018 |
Shen SC, Lofters A, Tinmouth J, Paszat L, Rabeneck L, Glazier RH. Predictors of non-adherence to colorectal cancer screening among immigrants to Ontario, Canada: a population-based study. Preventive Medicine. PMID 29548788 DOI: 10.1016/J.Ypmed.2018.03.002 |
0.683 |
|
| 2018 |
Bhatia D, Sutradhar R, Tinmouth J, Singh S, Lipscombe L. Abstract 2204: Influence of chronic comorbidities on colorectal cancer screening adherence in a population-based Canadian cohort Epidemiology. DOI: 10.1158/1538-7445.Am2018-2204 |
0.389 |
|
| 2018 |
Beintaris I, Rutter MD, Valori R, Chiu HM, Corley DA, Cuatrecasas M, Dekker E, Forsberg A, Gore-Booth J, Haug U, Kaminski MF, Matsuda T, Meijer GA, Morris E, Plumb AA, ... ... Tinmouth J, et al. PTU-031 The world endoscopy organisation consensus statements on post-colonoscopy and post-imaging colorectal cancer Gut. DOI: 10.1136/Gutjnl-2018-Bsgabstracts.372 |
0.323 |
|
| 2017 |
Dubé C, Yakubu M, McCurdy BR, Lischka A, Koné A, Walker MJ, Peirson L, Tinmouth J. Risk of Advanced Adenoma, Colorectal Cancer, and Colorectal Cancer Mortality in People With Low-Risk Adenomas at Baseline Colonoscopy: A Systematic Review and Meta-Analysis. The American Journal of Gastroenterology. PMID 29087393 DOI: 10.1038/Ajg.2017.360 |
0.354 |
|
| 2017 |
Catomeris P, Baxter NN, Boss SC, Paszat LF, Rabeneck L, Randell E, Serenity ML, Sutradhar R, Tinmouth J. Effect of Temperature and Time on Fecal Hemoglobin Stability in 5 Fecal Immunochemical Test Methods and One Guaiac Method. Archives of Pathology & Laboratory Medicine. PMID 28967803 DOI: 10.5858/Arpa.2016-0294-Oa |
0.336 |
|
| 2017 |
Paszat L, Sutradhar R, O'Brien MA, Lofters A, Pinto A, Selby P, Baxter N, Donnelly PD, Elliott R, Glazier RH, Kyle R, Manca D, Pietrusiak MA, Rabeneck L, Sopcak N, ... Tinmouth J, et al. BETTER HEALTH: Durham -- protocol for a cluster randomized trial of BETTER in community and public health settings. Bmc Public Health. 17: 754. PMID 28962558 DOI: 10.1186/S12889-017-4797-3 |
0.644 |
|
| 2017 |
Murthy SK, Dubé C, Rostom A, Benchimol EI, Ducharme R, Sutradhar R, Rabeneck L, Paszat L, Tinmouth J. Risk of colorectal cancer after a negative colonoscopy in low-to-moderate risk individuals: impact of a 10-year colonoscopy. Endoscopy. PMID 28915524 DOI: 10.1055/S-0043-117402 |
0.351 |
|
| 2017 |
James PD, Rabeneck L, Yun L, Paszat L, Baxter NN, Govindarajan A, Antonova L, Tinmouth JM. Repeated faecal occult blood testing is associated with decreased advanced colorectal cancer risk: A population-based study. Journal of Medical Screening. 969141317718860. PMID 28862521 DOI: 10.1177/0969141317718860 |
0.356 |
|
| 2017 |
Baxter NN, Sutradhar R, Li Q, Daly C, Honein-AbouHaidar GN, Richardson DP, Del Giudice L, Tinmouth J, Paszat L, Rabeneck L. Corrigendum: Do Primary Care Provider Strategies Improve Patient Participation in Colorectal Cancer Screening? The American Journal of Gastroenterology. PMID 28417995 DOI: 10.1038/Ajg.2017.119 |
0.411 |
|
| 2017 |
Stock D, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J. A centrally generated primary care physician audit report does not improve colonoscopy uptake after a positive result on a fecal occult blood test in Ontario's ColonCancerCheck program. Current Oncology (Toronto, Ont.). 24: 47-51. PMID 28270725 DOI: 10.3747/Co.24.3025 |
0.352 |
|
| 2017 |
Baxter NN, Sutradhar R, Li Q, Daly C, Honein-AbouHaidar GN, Richardson DP, Del Giudice L, Tinmouth J, Paszat L, Rabeneck L. Do Primary Care Provider Strategies Improve Patient Participation in Colorectal Cancer Screening? The American Journal of Gastroenterology. PMID 28244494 DOI: 10.1038/Ajg.2017.4 |
0.422 |
|
| 2017 |
Tinmouth J, Peeva V, Amare H, Blitz S, Raboud J, Sano M, Steele L, Salit IE. Progression From Perianal High-Grade Anal Intraepithelial Neoplasia to Anal Cancer in HIV-Positive Men Who Have Sex With Men. Diseases of the Colon and Rectum. 59: 836-42. PMID 27505112 DOI: 10.1097/Dcr.0000000000000644 |
0.604 |
|
| 2017 |
Tinmouth J, Jembere N, Gao J, McCurdy B, Sacco J, Holloway C, Kennedy E, Dube C. Reduction in Wait-Times to Colonoscopy after Positive Fecal Occult Blood Test Among Patients having Colonoscopy in a Diagnostic Assessment Program Compared to Usual Care in Ontario's Organized Colorectal Cancer Screening Program Gastroenterology. 152: S74. DOI: 10.1016/S0016-5085(17)30601-7 |
0.361 |
|
| 2016 |
Lipscombe L, Fischer H, Tinmouth J, Austin P, Fung K, Cheung MC. Choosing Wisely in oncology: Screening for a new primary cancer in patients with metastatic disease. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 295. PMID 28152876 DOI: 10.1200/Jco.2016.34.7_Suppl.295 |
0.402 |
|
| 2016 |
Ritvo P, Myers RE, Serenity M, Gupta S, Inadomi JM, Green B, Jerant A, Tinmouth J, Paszat L, Meysam P, Rabeneck L. Taxonomy for colorectal cancer screening promotion: Lessons from recent randomized controlled trials. Preventive Medicine. PMID 28024865 DOI: 10.1016/j.ypmed.2016.12.024 |
0.326 |
|
| 2016 |
Jonah L, Pefoyo AK, Lee A, Hader J, Strasberg S, Kupets R, Chiarelli AM, Tinmouth J. Evaluation of the effect of an audit and feedback reporting tool on screening participation: The Primary Care Screening Activity Report (PCSAR). Preventive Medicine. PMID 27923667 DOI: 10.1016/J.Ypmed.2016.12.002 |
0.404 |
|
| 2016 |
Tinmouth J, Vella ET, Baxter NN, Dubé C, Gould M, Hey A, Ismaila N, McCurdy BR, Paszat L. Colorectal Cancer Screening in Average Risk Populations: Evidence Summary. Canadian Journal of Gastroenterology & Hepatology. 2016: 2878149. PMID 27597935 DOI: 10.1155/2016/2878149 |
0.407 |
|
| 2016 |
Borowiec AM, Wang CS, Yong E, Law C, Coburn N, Sutradhar R, Baxter N, Paszat L, Tinmouth J. Colonic Stents for Colorectal Cancer Are Seldom Used and Mainly for Palliation of Obstruction: A Population-Based Study. Canadian Journal of Gastroenterology & Hepatology. 2016: 1945172. PMID 27446826 DOI: 10.1155/2016/1945172 |
0.334 |
|
| 2016 |
Dube C, Yakubu M, McCurdy B, Lischka A, Tinmouth J. 252 Risk of Advanced Adenoma, Colorectal Cancer, and Colorectal Cancer Mortality in Individuals With Low Risk Adenomas on Baseline Colonoscopy: A Systematic Review and Meta-Analysis Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)30326-2 |
0.356 |
|
| 2015 |
Fernandes KA, Sutradhar R, Borkhoff CM, Baxter N, Lofters A, Rabeneck L, Tinmouth J, Paszat L. Small-area variation in screening for cancer, glucose and cholesterol in Ontario: a cross-sectional study. Cmaj Open. 3: E373-81. PMID 26835437 DOI: 10.9778/cmajo.20140069 |
0.567 |
|
| 2015 |
Correia A, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J. Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices Preventive Medicine. 76: 115-122. PMID 25895843 DOI: 10.1016/J.Ypmed.2015.03.028 |
0.387 |
|
| 2015 |
Govindarajan A, Rabeneck L, Yun L, Tinmouth J, Paszat LF, Baxter NN. Population-based assessment of the outcomes in patients with postcolonoscopy colorectal cancers. Gut. PMID 25748649 DOI: 10.1136/Gutjnl-2014-308578 |
0.331 |
|
| 2015 |
Ritvo PG, Myers RE, Paszat LF, Tinmouth JM, McColeman J, Mitchell B, Serenity M, Rabeneck L. Personal navigation increases colorectal cancer screening uptake. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 506-11. PMID 25378365 DOI: 10.1158/1055-9965.EPI-14-0744 |
0.348 |
|
| 2015 |
Tinmouth J, Patel J, Austin PC, Baxter NN, Brouwers MC, Earle C, Levitt C, Lu Y, Mackinnon M, Paszat L, Rabeneck L. Increasing participation in colorectal cancer screening: Results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders International Journal of Cancer. 136. PMID 25195923 DOI: 10.1002/Ijc.29191 |
0.405 |
|
| 2015 |
Stock D, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J. Mailed participant reminders are associated with improved colonoscopy uptake after a positive FOBT result in Ontario's ColonCancerCheck program Implementation Science. 10. DOI: 10.1186/S13012-015-0226-0 |
0.376 |
|
| 2015 |
Tinmouth JM, Patel J, Austin PC, Baxter NN, Brouwers MC, Earle C, Levitt CA, Lu Y, Mackinnon M, Paszat L, Rabeneck L. Mo1964 A Cluster Randomized Trial of Directly Mailed gFoBT Kits to Previous Responders Being Recalled for Screening Gastroenterology. 148. DOI: 10.1016/S0016-5085(15)32573-7 |
0.341 |
|
| 2015 |
Tinmouth JM, Llovet D, Lee A, Hader JM, Kone A, Sutradhar R, Rabeneck L, Tsiplova K, Paszat L. 824 Tailored Versus Non-Tailored Invitations for Colorectal Cancer Screening in Ontario's Coloncancercheck Program: Two Randomized Controlled Trials Gastroenterology. 148. DOI: 10.1016/S0016-5085(15)30541-2 |
0.417 |
|
| 2015 |
Tinmouth JM, Lim T, Kone A, Mccurdy B, Dube C, Rabeneck L. 968 Risk of Colorectal Cancer Among Those Who Are gFOBt Positive but Have Had a Recent Prior Colonoscopy: Experience From an Organized Screening Program Gastrointestinal Endoscopy. 81: AB181. DOI: 10.1016/J.Gie.2015.03.1264 |
0.366 |
|
| 2014 |
Daly C, Li Q, Sutradhar R, Del Giudice EM, Paszat LF, Tinmouth J, Rabeneck L, Baxter NN. The impact of physician use of electronic medical records on colorectal cancer screening. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 288. PMID 28141215 DOI: 10.1200/Jco.2014.32.30_Suppl.288 |
0.396 |
|
| 2014 |
Honein-AbouHaidar GN, Rabeneck L, Paszat LF, Sutradhar R, Tinmouth J, Baxter NN. Evaluating the impact of public health initiatives on trends in fecal occult blood test participation in Ontario. Bmc Cancer. 14: 537. PMID 25062552 DOI: 10.1186/1471-2407-14-537 |
0.367 |
|
| 2014 |
Tinmouth J, Kennedy EB, Baron D, Burke M, Feinberg S, Gould M, Baxter N, Lewis N. Colonoscopy quality assurance in Ontario: Systematic review and clinical practice guideline. Canadian Journal of Gastroenterology & Hepatology. 28: 251-74. PMID 24839621 DOI: 10.1155/2014/262816 |
0.359 |
|
| 2014 |
Patel J, Salit IE, Berry MJ, de Pokomandy A, Nathan M, Fishman F, Palefsky J, Tinmouth J. Environmental scan of anal cancer screening practices: worldwide survey results. Cancer Medicine. 3: 1052-61. PMID 24740973 DOI: 10.1002/Cam4.250 |
0.425 |
|
| 2014 |
Honein-Abouhaidar GN, Kastner M, Vuong V, Perrier L, Rabeneck L, Tinmouth J, Straus S, Baxter NN. Benefits and barriers to participation in colorectal cancer screening: a protocol for a systematic review and synthesis of qualitative studies. Bmj Open. 4: e004508. PMID 24578543 DOI: 10.1136/Bmjopen-2013-004508 |
0.381 |
|
| 2014 |
Rabeneck L, Tinmouth JM, Paszat LF, Baxter NN, Marrett LD, Ruco A, Lewis N, Gao J. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 508-15. PMID 24443406 DOI: 10.1158/1055-9965.Epi-13-0956 |
0.351 |
|
| 2014 |
Cooper MA, Tinmouth JM, Rabeneck L. Registered nurse-performed flexible sigmoidoscopy in Ontario: development and implementaton of the curriculum and program. Canadian Journal of Gastroenterology & Hepatology. 28: 13-8. PMID 24416735 DOI: 10.1155/2014/561749 |
0.331 |
|
| 2014 |
Govindarajan A, Rabeneck L, Tinmouth J, Paszat LF, Baxter N. Impact of colonoscopically missed cancers on patient outcomes. Journal of Clinical Oncology. 32: 404-404. DOI: 10.1200/Jco.2014.32.3_Suppl.404 |
0.353 |
|
| 2014 |
Mittmann N, Hassan S, Patel J, Tinmouth JM. Mo1065 Cost-Effectiveness of Directly Mailed FOBT Kits in a Hard to Reach Population in Colorectal Cancer Screening Gastroenterology. 146: S-547. DOI: 10.1016/S0016-5085(14)61980-6 |
0.311 |
|
| 2014 |
Tinmouth JM, Rabeneck L, Baxter NN, Paszat L, Randell E, Sutradhar R, Serenit M. 118 Optimizing Implementation of Fecal Immunochemical Testing in Organized Colorectal Cancer Screening: A Randomized Controlled Trial Gastroenterology. 146: S-32-S-33. DOI: 10.1016/S0016-5085(14)60113-X |
0.407 |
|
| 2013 |
Borkhoff CM, Saskin R, Rabeneck L, Baxter NN, Liu Y, Tinmouth J, Paszat LF. Disparities in receipt of screening tests for cancer, diabetes and high cholesterol in Ontario, Canada: a population-based study using area-based methods. Canadian Journal of Public Health = Revue Canadienne De Sante Publique. 104: e284-90. PMID 24044467 DOI: 10.17269/Cjph.104.3699 |
0.351 |
|
| 2013 |
Salit IE, Blitz S, Collins E, Aggarwal B, Raboud J, Tinmouth J, Kovacs C, Conway D, Hedgcock M, Merkley B, Fletcher D, Calzavara L. 38. Anal cancer screening in HIV primary care: uptake and outcomes Sexual Health. 10: 588. DOI: 10.1071/Shv10N6Ab38 |
0.403 |
|
| 2013 |
Tinmouth JM, Patel J, Austin PC, Baxter NN, Brouwers M, Earle C, Levitt CA, Mackinnon M, Paszat L, Rabeneck L. 216 Increasing Participation in Colorectal Cancer Screening: Results From a Randomized Trial of Directly Mailed FOBT Kits in a Hard to Reach Population Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)60162-6 |
0.427 |
|
| 2012 |
Tinmouth JM, Hsieh E, Saskin R, Baxter NN, Govindarajan A, Hilsden RJ, McGregor SE, Paszat L, Rabeneck L. Mo1033 Sessile Serrated Polyps at Screening Colonoscopy: Have They Been Under Diagnosed? Gastroenterology. 142: S-577. DOI: 10.1016/S0016-5085(12)62215-X |
0.345 |
|
| 2012 |
James PD, Rabeneck L, Yun L, Paszat L, Baxter NN, Govindarajan A, Tinmouth JM. 892 Regular Screening With FOBT is Associated With Detection of Colorectal Cancer at an Earlier Stage: A Population-Based Study Gastroenterology. 142: S-156. DOI: 10.1016/S0016-5085(12)60588-5 |
0.374 |
|
| 2012 |
Tinmouth JM, Paszat L, Baxter NN, Sutradhar R, Yun L, Rabeneck L. 888 Mailed Invitations to Be Screened for Colorectal Cancer Improve Uptake in Population Based Screening Program Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)60584-8 |
0.41 |
|
| 2011 |
McGregor SE, Ritvo P, Tinmouth J, Kornblum A, Myers R, Hilsden RJ, Paszat LF, Rabeneck L. Reactions to a targeted intervention to increase fecal occult blood testing among average-risk adults waiting for screening colonoscopy. Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 25: 248-52. PMID 21647457 DOI: 10.1155/2011/397302 |
0.364 |
|
| 2011 |
Lam JM, Hoch JS, Tinmouth J, Sano M, Raboud J, Salit IE. Cost-effectiveness of screening for anal precancers in HIV-positive men. Aids (London, England). 25: 635-42. PMID 21139488 DOI: 10.1097/Qad.0B013E3283434594 |
0.304 |
|
| 2010 |
Sewitch MJ, Stein D, Joseph L, Bitton A, Hilsden RJ, Rabeneck L, Paszat L, Tinmouth J, Cooper MA. Comparing patient and endoscopist perceptions of the colonoscopy indication. Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 24: 656-60. PMID 21157580 DOI: 10.1155/2010/328178 |
0.336 |
|
| 2010 |
Salit IE, Lytwyn A, Raboud J, Sano M, Chong S, Diong C, Chapman W, Mahony JB, Tinmouth J. The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening. Aids (London, England). 24: 1307-13. PMID 20442633 DOI: 10.1097/Qad.0B013E328339E592 |
0.325 |
|
| 2010 |
Allard J, Cosby R, Del Giudice ME, Irvine EJ, Morgan D, Tinmouth J. Gastroscopy following a positive fecal occult blood test and negative colonoscopy: Systematic review and guideline Canadian Journal of Gastroenterology. 24: 113-120. PMID 20151070 DOI: 10.1155/2010/516363 |
0.4 |
|
| 2009 |
Steele LS, Ross LE, Dobinson C, Veldhuizen S, Tinmouth JM. Women's sexual orientation and health: results from a Canadian population-based survey. Women & Health. 49: 353-67. PMID 19851942 DOI: 10.1080/03630240903238685 |
0.592 |
|
| 2009 |
Salit IE, Tinmouth J, Chong S, Raboud J, Diong C, Su D, Sano M, Lytwyn A, Chapman W, Mahony J. Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1986-92. PMID 19567510 DOI: 10.1158/1055-9965.Epi-08-1141 |
0.31 |
|
| 2009 |
Jiménez W, Paszat L, Kupets R, Wilton A, Tinmouth J. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario. Gynecologic Oncology. 114: 395-8. PMID 19501390 DOI: 10.1016/J.Ygyno.2009.05.006 |
0.302 |
|
| 2007 |
Tinmouth J, Tomlinson G, Kandel G, Walmsley S, Steinhart AH, Glazier R. Evaluation of stool frequency and stool form as measures of HIV-related diarrhea Hiv Clinical Trials. 8: 421-428. PMID 18042507 DOI: 10.1310/Hct0806-421 |
0.463 |
|
| 2007 |
Tinmouth J, Kandel G, Tomlinson G, Walmsley S, Steinhart AH, Glazier R. Systematic review of strategies to measure HIV-related diarrhea Hiv Clinical Trials. 8: 155-163. PMID 17621462 DOI: 10.1310/Hct0803-155 |
0.485 |
|
| 2006 |
Steele LS, Tinmouth JM, Lu A. Regular health care use by lesbians: a path analysis of predictive factors. Family Practice. 23: 631-6. PMID 16799166 DOI: 10.1093/Fampra/Cml030 |
0.628 |
|
| 2006 |
Tinmouth J, Kandel G, Tomlinson G, Walmsley S, Steinhart AH, Glazier R. The effect of dairy product ingestion on human immunodeficiency virus-related diarrhea in a sample of predominantly gay men: a randomized, controlled, double-blind, crossover trial. Archives of Internal Medicine. 166: 1178-83. PMID 16772244 DOI: 10.1001/Archinte.166.11.1178 |
0.504 |
|
| 2006 |
Tinmouth J, Paszat L, Rabeneck L. Anal Cancer in Ontario, 1971–2002: The Relationship to Socioeconomic Status, Gender and the HIV Epidemic The American Journal of Gastroenterology. 101. DOI: 10.14309/00000434-200609001-01066 |
0.3 |
|
| 2004 |
Tinmouth JM, Steele LS, Tomlinson G, Glazier RH. Are claims of equivalency in digestive diseases trials supported by the evidence? Gastroenterology. 126: 1700-10. PMID 15188165 DOI: 10.1053/J.Gastro.2004.03.005 |
0.696 |
|
| 2004 |
Tinmouth JM, Steele LS, Tomlinson G, Glazier R, Kane S. It seems that all trials are not created equal Evidence-Based Gastroenterology. 5: 104. DOI: 10.1097/00132579-200411000-00001 |
0.612 |
|
| 2003 |
Tinmouth JM, Steele LS, Tomlinson GA, Glazier R. RANDOMIZED CONTROLLED TRIALS CLAIMING EQUIVALENCY IN DIGESTIVE DISEASES: ARE THEY METHODOLOGICALLY RIGOROUS? American Journal of Gastroenterology. 98: S76. DOI: 10.1111/j.1572-0241.2003.07958.x |
0.624 |
|
| 2003 |
Tinmouth JM, Steele LS, Tomlinson GA, Glazier R. Randomized controlled trials claiming equivalency in digestive diseases: are they methodologically rigorous? The American Journal of Gastroenterology. 98. DOI: 10.1016/S0002-9270(03)00991-2 |
0.689 |
|
| Show low-probability matches. |